Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin United Pharmaceutical is a prominent Chinese pharmaceutical enterprise engaged in the integrated research, development, and large-scale production of chemical pharmaceuticals. The company's product portfolio is heavily weighted toward chronic disease management, featuring essential medicines for cardiovascular health, metabolic disorders, and gastrointestinal conditions. Operating under the umbrella of the Tianjin Pharmaceutical Group, it utilizes advanced GMP-certified facilities to manufacture both active pharmaceutical ingredients and finished dosage forms. Tianjin United Pharmaceutical serves as a significant supplier in the Chinese domestic market while also expanding its footprint through international exports and contract manufacturing partnerships. The company is recognized for its high-quality production standards and its role in the regional pharmaceutical industrial cluster in the Tianjin Economic-Technological Development Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin United Pharmaceutical.